Clinical trial
A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease; a Phase IIb Study
NCT01458470 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease; a Phase IIb Study
- Lead sponsor
- University of British Columbia
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- November 30, 2012
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.